93,900 Shares in KORU Medical Systems, Inc. $KRMD Purchased by OMERS ADMINISTRATION Corp

Key Points

• OMERS ADMINISTRATION Corp has acquired a new stake in KORU Medical Systems, purchasing 93,900 shares valued at approximately $239,000, representing about 0.20% of the company.
• KORU Medical Systems recently reported an earnings per share (EPS) of $0.01, exceeding analysts' expectations, alongside a revenue of $10.20 million for the quarter.
• Despite a negative P/E ratio of -45.56, KORU Medical Systems maintains an average analyst rating of "Buy" with a consensus target price of $4.63.

OMERS ADMINISTRATION Corp purchased a new stake in KORU Medical Systems, Inc. (NASDAQ:KRMD - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 93,900 shares of the company's stock, valued at approximately $239,000. OMERS ADMINISTRATION Corp owned approximately 0.20% of KORU Medical Systems as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the company. Russell Investments Group Ltd. increased its position in shares of KORU Medical Systems by 220.5% in the first quarter. Russell Investments Group Ltd. now owns 214,908 shares of the company's stock valued at $546,000 after buying an additional 147,857 shares in the last quarter. HighTower Advisors LLC increased its position in shares of KORU Medical Systems by 18.4% in the first quarter. HighTower Advisors LLC now owns 51,400 shares of the company's stock valued at $131,000 after buying an additional 8,000 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its position in shares of KORU Medical Systems by 11.8% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 66,917 shares of the company's stock valued at $170,000 after buying an additional 7,046 shares in the last quarter. Calamos Advisors LLC increased its position in shares of KORU Medical Systems by 36.5% in the first quarter. Calamos Advisors LLC now owns 88,718 shares of the company's stock valued at $225,000 after buying an additional 23,729 shares in the last quarter. Finally, Jefferies Financial Group Inc. purchased a new position in shares of KORU Medical Systems in the fourth quarter valued at $132,000. Hedge funds and other institutional investors own 58.60% of the company's stock.

KORU Medical Systems Price Performance

Shares of KRMD stock traded up $0.03 during mid-day trading on Wednesday, reaching $4.04. The stock had a trading volume of 53,941 shares, compared to its average volume of 75,204. KORU Medical Systems, Inc. has a 12-month low of $1.86 and a 12-month high of $5.05. The company has a market cap of $186.81 million, a P/E ratio of -44.89 and a beta of 0.57. The business has a 50-day simple moving average of $3.79 and a 200 day simple moving average of $3.21. The company has a current ratio of 2.91, a quick ratio of 2.25 and a debt-to-equity ratio of 0.01.

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.01 earnings per share for the quarter, beating analysts' consensus estimates of ($0.03) by $0.04. The business had revenue of $10.20 million during the quarter, compared to analysts' expectations of $9.46 million. KORU Medical Systems had a negative return on equity of 26.77% and a negative net margin of 12.24%. On average, sell-side analysts anticipate that KORU Medical Systems, Inc. will post -0.13 earnings per share for the current year.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.